Emerging evidence in neuroimmunology indicates that upregulation of major histocompatibility complex (MHC) components, specifically MHC class I and II isoforms, may orchestrate immunoregulatory signaling within glioblastoma microenvironments. Here, HLA-C is linked to glioblastoma.